Application of quercetin and/or medicinal derivative thereof in preparation of anti-enterovirus drugs
The invention provides application of quercetin and/or medicinal derivatives thereof in preparation of anti-enterovirus drugs, and proves that quercetin has relatively strong antiviral activity on enteroviruses such as EV71, CVB4 and the like, and can significantly inhibit cytopathic effect (CPE) generated by the enteroviruses on host cells RD and enhance cell survival rate; and the quercetin can inhibit virus replication, shows a strong antiviral effect at a cellular level, and has an obvious technical effect Results of the invention show that the compound quercetin has potential to prepare specific treatment drugs for resisting enteric infection, and has good clinical application prospects..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Europäisches Patentamt - (2021) vom: 10. Dez. Zur Gesamtaufnahme - year:2021 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
YANG QINGYU [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-12-10, Last update posted on www.tib.eu: 2022-10-03, Last updated: 2023-02-09 |
---|
Patentnummer: |
CN113768920 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA013850334 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA013850334 | ||
003 | DE-627 | ||
005 | 20230504124936.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230215s2021 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA013850334 | ||
035 | |a (EPA)CN113768920 | ||
035 | |a (EPA)78841149 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a YANG QINGYU |e verfasserin |4 aut | |
245 | 1 | 0 | |a Application of quercetin and/or medicinal derivative thereof in preparation of anti-enterovirus drugs |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2021-12-10, Last update posted on www.tib.eu: 2022-10-03, Last updated: 2023-02-09 | ||
520 | |a The invention provides application of quercetin and/or medicinal derivatives thereof in preparation of anti-enterovirus drugs, and proves that quercetin has relatively strong antiviral activity on enteroviruses such as EV71, CVB4 and the like, and can significantly inhibit cytopathic effect (CPE) generated by the enteroviruses on host cells RD and enhance cell survival rate; and the quercetin can inhibit virus replication, shows a strong antiviral effect at a cellular level, and has an obvious technical effect Results of the invention show that the compound quercetin has potential to prepare specific treatment drugs for resisting enteric infection, and has good clinical application prospects. | ||
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a 615 | |
700 | 0 | |a ZHANG DINGYU |4 aut | |
700 | 0 | |a HUANG CHAOLIN |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 10. Dez. |
773 | 1 | 8 | |g year:2021 |g day:10 |g month:12 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/78841149/publication/CN113768920A1?q=CN113768920 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |j 2021 |b 10 |c 12 |
951 | |a AR | ||
952 | |j 2021 |b 10 |c 12 |